PharmaVoice
AUGUST 24, 2022
Diversity in clinical trials isn’t only important for the health of the overall patient population — it can save millions in lost profits.
Drug Topics
AUGUST 24, 2022
A recent review suggests that atomoxetine can reduce symptoms of anxiety in children and adolescents with ADHD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
AUGUST 24, 2022
How the chief medical officer of the emerging diagnostic company is using the patient perspective as a guiding light.
Pharmacy Times
AUGUST 24, 2022
Auvelity is a combination of dextromethorphan and bupropion indicated for the treatment of major depressive disorder in adults.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
AUGUST 24, 2022
How the latest personnel shifts are impacting each company and the industry at large.
Pharmacy Times
AUGUST 24, 2022
Drs. Abraham, Chopra and Feuerstadt discuss importance of timely referral and diagnostic methods to discern C. difficile infection (CDI).
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 24, 2022
Precise, more potent therapy can offer reduced toxicity.
pharmaphorum
AUGUST 24, 2022
Diversity in clinical trials is a “scientific imperative”, but how can industry bridge the gap between “why” and “how”? Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done. The Food and Drug Administration’s (FDA) draft guidance, Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Subgroups in Clinical Trials , recommends sponsors
Pharmacy Times
AUGUST 24, 2022
The phase 2 study will evaluate the efficacy and safety of 2 different doses of MK-2060 in patients with ESRD receiving hemodialysis via an arteriovenous graft.
European Pharmaceutical Review
AUGUST 24, 2022
A strategic approach to optimisations of testing bacterial endotoxins. Given industry’s recent focus on the sustainability of bacterial endotoxin testing (BET), here, AstraZeneca colleagues Miriam Guest, Karen Capper, Dennis Wong and Phil Duncanson share how they worked to establish a short-, mid- and long-term strategy to optimise BET across the global enterprise.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 24, 2022
A systematic review of literature found that family history of psychiatric disorders is a risk factor associated with postpartum depression, adding to a contradictory body of research.
European Pharmaceutical Review
AUGUST 24, 2022
Included in this issue: NITROSAMINES. Risks presented by active pharmaceutical ingredient nitrosamines. David Elder, David P Elder Consultancy. ENVIRONMENTAL MONITORING. Progress in the implementation of biofluorescent particle counters. Hannah Balfour with comment from Mike Russ at Genentech. REGULATORY INSIGHT. The EU HTA regulation: a new frontier for access to innovative technologies.
Pharmacy Times
AUGUST 24, 2022
Danish analysis looks at the relationship between the therapy and cardiovascular adverse effects, particularly arrhythmias.
European Pharmaceutical Review
AUGUST 24, 2022
With companies striving to produce cost-effective and high?quality therapeutics, utilising the most efficient methods possible has become a critical focus. Thus, the lengthy incubation periods needed with traditional culture?based microbiological monitoring techniques have long been a source of frustration. The introduction of alternative and rapid microbiological methods (ARMMs), without such extensive time requirements, is therefore helping companies overcome such limitations.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 24, 2022
The 4 academic centers will evaluate the role of telehealth in areas such as prevention, screening, diagnosis, treatment, and survivorship.
PharmExec
AUGUST 24, 2022
The two technologies are helping HCPs spread information and collect data in new ways.
Pharmacy Times
AUGUST 24, 2022
Survey data indicates that people experiencing homelessness had a lower annual incidence of COVID-19 despite having a higher burden of infectious diseases, suggesting opportunities for better integration of homelessness status in infectious disease reporting.
European Pharmaceutical Review
AUGUST 24, 2022
The topic of bacterial endotoxin testing (BET), while a unique requirement for the pharmaceutical industry, has far?reaching impact. In recent years, articles on the reliance on the horseshoe crab within the pharmaceutical industry 1-3 and considerations for alternative testing strategies have been widely discussed. 4-7 Here, the approach taken at AstraZeneca to optimise test methodology to provide assurance of patient safety, reduce the burden on a natural resource and continue to improve in th
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
AUGUST 24, 2022
Dr. Chopra shares multipronged approach to reducing C. difficile infection (CDI) and the role of antimicrobial stewardship.
BuzzRx
AUGUST 24, 2022
Deep brain stimulation (DBS) is one of the surgical treatments performed to treat Parkinson's disease. It involves the placement of a deep brain stimulator (metal wires in the brain connected to a pulse generator in the chest). Abnormal electrical signals in the brain cause the motor complications seen in Parkinson’s disease. Deep brain stimulation works by regulating electrical stimulation in certain parts of the brain.
Pharmacy Times
AUGUST 24, 2022
Early detection of chronic kidney disease is vital to preventing comorbid conditions.
pharmaphorum
AUGUST 24, 2022
Amgen has reported positive phase 3 results with its biosimilar version of AstraZeneca/Alexion’s blockbuster rare disease drug Soliris, setting up a regulatory filing with the FDA. The biotech has confirmed it will not launch the biosimilar until March 2025 however, honouring the terms of its 2020 agreement with Alexion that resolved litigation over the validity of patents covering Soliris (eculizumab) in the US.
Pharmacy Times
AUGUST 24, 2022
Evaluating nonprescription medications, including dietary supplements, can prevent adverse effects.
Pharma Times
AUGUST 24, 2022
The phase 2/3 trial results showed that the vaccine was effective in protecting children
Pharmacy Times
AUGUST 24, 2022
Acetaminophen helps to reduce fevers and treat headaches, pains, and menstrual cramps.
Pharmafile
AUGUST 24, 2022
WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected tropical diseases (NTDs). The West African nation has successfully eliminated dracunculiasis (Guinea worm disease), elephantiasis (lymphatic filariasis), human African trypanosomiasis (sleeping sickness) and trachoma, in an effort spanning between 2011 and 2022. read more.
Pharmacy Times
AUGUST 24, 2022
High-level ethical decision making considers various ethical components and all stakeholders.
Pharmafile
AUGUST 24, 2022
Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, and regulatory approval of a PIP is a pre-requisite for application for approval of a new medicine for adult patients. Northwest Biotherapeutics is a biotech company developing DCVax personalised immune therapies for solid cancers.
Pharmacy Times
AUGUST 24, 2022
This month's generic product new features vilazadone tablets, leuprolide acetate injection, and oxcarbazepine tablets.
Pharmafile
AUGUST 24, 2022
The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ smallpox drug Tpoxx can be used to fight the outbreak. The PLATINUM trial is now recruiting up to 500 patients across the UK to see if Tpoxx (tecovirimat), an antiviral drug that prevents the virus from leaving infected cells, can help people with monkeypox get better more quickly, and shorten the time that they are infectious to others. read more.
Pharmacy Times
AUGUST 24, 2022
George Rafferty and Jason Dinger of AmerisourceBergen discuss the investment interests of the venture capital fund AB Health Ventures within the retail pharmacy space.
Pharmafile
AUGUST 24, 2022
A new study has revealed the range and type of illnesses that people with type 2 diabetes are living with, highlighting the urgent need for a more personalised approach to care for these patients. The 1st and 5th most common comorbidities identified were hypertension and heart disease, conditions well known to have links with diabetes. For the first time, research has linked back pain, depression, and osteoarthritis as those included in the five most common conditions at diagnosis. read more.
Compounding Pharmacy of America
AUGUST 24, 2022
Good oral hygiene doesn’t protect just your teeth. Your oral hygiene plays a critical role in your overall health and what happens in your mouth can affect almost every other part of your body. When health professionals look in your mouth, your oral health can show symptoms of serious conditions like heart disease, diabetes and […]. The post What Health Problems Are Related to Poor Oral Hygiene?
Expert insights. Personalized for you.
265 
Let's personalize your content